Article from the Global AMR R&D Hub newsletter, August 2021 edition
One of the challenges inhibiting more unified and coordinated global action in the field of incentives for AMR product development, is a lack of evidence and data to quantify the need or size of the challenge and therefore the scale of the required intervention.
To help address this knowledge gap, the Global AMR R&D Hub established an Expert Advisory Group (EAG), with broad geographic and technical representation across the One Health spectrum, in May 2019. The EAG was tasked with estimating the global market potential for products (diagnostics and therapeutics) that they identified as representing some of the greatest unmet medical need for addressing AMR.
The Hub is proud to publish the results of this in-depth analysis and offer policy insights and recommendations for progress within the field. We hope that by showing the astonishing mismatch between global needs and commercial potential, this study will help mobilise the required action to both support innovation and ensure these necessary new products are accessible to those with the greatest need around the world.
Read the full report and accompanying Policy Briefs here.